Prosthesis–patient mismatch in high-risk patients with severe aortic stenosis: A randomized trial of a self-expanding prosthesis

Abstract Objectives We compared the incidence of prosthesis–patient mismatch (PPM) between transcatheter aortic valve replacement (TAVR) using a self-expanding bioprosthesis and surgical aortic valve replacement (SAVR) in the CoreValve US High Risk Pivotal Trial. We sought to determine the influence...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of thoracic and cardiovascular surgery 2016-04, Vol.151 (4), p.1014-1023.e3
Hauptverfasser: Zorn, George L., MD, Little, Stephen H., MD, Tadros, Peter, MD, Deeb, G. Michael, MD, Gleason, Thomas G., MD, Heiser, John, MD, Kleiman, Neal S., MD, Oh, Jae K., MD, Popma, Jeffrey J., MD, Adams, David, MD, Huang, Jian, MD, Reardon, Michael J., MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1023.e3
container_issue 4
container_start_page 1014
container_title The Journal of thoracic and cardiovascular surgery
container_volume 151
creator Zorn, George L., MD
Little, Stephen H., MD
Tadros, Peter, MD
Deeb, G. Michael, MD
Gleason, Thomas G., MD
Heiser, John, MD
Kleiman, Neal S., MD
Oh, Jae K., MD
Popma, Jeffrey J., MD
Adams, David, MD
Huang, Jian, MD
Reardon, Michael J., MD
description Abstract Objectives We compared the incidence of prosthesis–patient mismatch (PPM) between transcatheter aortic valve replacement (TAVR) using a self-expanding bioprosthesis and surgical aortic valve replacement (SAVR) in the CoreValve US High Risk Pivotal Trial. We sought to determine the influence of PPM on clinical outcomes. Methods Patients with severe aortic stenosis and at increased risk for surgery were randomized 1:1 to TAVR or SAVR. Postoperative PPM was defined by the effective orifice area index (EOAi) as severe PPM (EOAi ≤ 0.65 cm2 /m2 ) and no severe PPM (EOAi > 0.65 cm2 /m2 ); clinical outcomes were analyzed in the TAVR arm (n = 389) and SAVR arm (n = 353). Left ventricular mass index and regression were analyzed at baseline and 1 year. Results The incidence of severe PPM in the SAVR group at 1 year was 25.7% versus 6.2% in the TAVR group ( P  
doi_str_mv 10.1016/j.jtcvs.2015.10.070
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1775165042</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022522315021339</els_id><sourcerecordid>1775165042</sourcerecordid><originalsourceid>FETCH-LOGICAL-c459t-c7fa03d60c796e473626ff16de414a534f70d493176385c511e20cc0e4fde2173</originalsourceid><addsrcrecordid>eNqFkcuKFTEQhoMoznH0CQTJ0k0fU7lOCwrD4A0GFFRwF2K6ejo9fTkmOWccV-Ir-IY-iWnPcRZuXAWq_r_-1FeEPAS2Bgb6Sb_us9-lNWegSmXNDLtFVsBqU-kT9ek2WTHGeaU4F0fkXko9Y0UC9V1yxLUGKYGvyI93cU65wxTSr-8_Ny4HnDIdQxpd9h0NE-3CRVfFkC7poZvoVcgdTbjDiNTNMQdPU8ZpLkOe0lMa3dTMY_iGDc0xuIHOLXVFP7QVft2UZpgu6OYm9z6507oh4YPDe0w-vnzx4ex1df721Zuz0_PKS1XnypvWMdFo5k2tURqhuW5b0A1KkE4J2RrWyFqA0eJEeQWAnHnPULYNcjDimDzezy3RX7aYsi1rehwGN-G8TRaMUaAVk7xIxV7qyy9TxNZuYhhdvLbA7ALf9vYPfLvAX4qFbHE9OgRsP4_Y3Hj-0i6CZ3sBljV3AaNNvhD12ISIPttmDv8JeP6P3w9hCt4Nl3iNqZ-3cSoELdjELbPvl_sv5wfFOAhRi99kZa6w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1775165042</pqid></control><display><type>article</type><title>Prosthesis–patient mismatch in high-risk patients with severe aortic stenosis: A randomized trial of a self-expanding prosthesis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Zorn, George L., MD ; Little, Stephen H., MD ; Tadros, Peter, MD ; Deeb, G. Michael, MD ; Gleason, Thomas G., MD ; Heiser, John, MD ; Kleiman, Neal S., MD ; Oh, Jae K., MD ; Popma, Jeffrey J., MD ; Adams, David, MD ; Huang, Jian, MD ; Reardon, Michael J., MD</creator><creatorcontrib>Zorn, George L., MD ; Little, Stephen H., MD ; Tadros, Peter, MD ; Deeb, G. Michael, MD ; Gleason, Thomas G., MD ; Heiser, John, MD ; Kleiman, Neal S., MD ; Oh, Jae K., MD ; Popma, Jeffrey J., MD ; Adams, David, MD ; Huang, Jian, MD ; Reardon, Michael J., MD</creatorcontrib><description>Abstract Objectives We compared the incidence of prosthesis–patient mismatch (PPM) between transcatheter aortic valve replacement (TAVR) using a self-expanding bioprosthesis and surgical aortic valve replacement (SAVR) in the CoreValve US High Risk Pivotal Trial. We sought to determine the influence of PPM on clinical outcomes. Methods Patients with severe aortic stenosis and at increased risk for surgery were randomized 1:1 to TAVR or SAVR. Postoperative PPM was defined by the effective orifice area index (EOAi) as severe PPM (EOAi ≤ 0.65 cm2 /m2 ) and no severe PPM (EOAi &gt; 0.65 cm2 /m2 ); clinical outcomes were analyzed in the TAVR arm (n = 389) and SAVR arm (n = 353). Left ventricular mass index and regression were analyzed at baseline and 1 year. Results The incidence of severe PPM in the SAVR group at 1 year was 25.7% versus 6.2% in the TAVR group ( P  &lt; .0001). Left ventricular mass index regression at 1 year was 6.8% for TAVR and 15.1% for SAVR in patients with severe PPM. At 1 year the rate of all-cause mortality and acute kidney injury were significantly greater in all patients (TAVR + SAVR) with severe PPM compared with no severe PPM (20.6% vs 12.0% [ P  = .0145] for death and 19.2% vs 8.5% [ P  = .0008] for acute kidney injury). Conclusions In patients with high surgical risk and severe aortic stenosis, severe PPM is more common in patients treated with SAVR than those treated with TAVR. Patients with severe PPM are a greater risk for death and acute kidney injury than patients without severe PPM.</description><identifier>ISSN: 0022-5223</identifier><identifier>EISSN: 1097-685X</identifier><identifier>DOI: 10.1016/j.jtcvs.2015.10.070</identifier><identifier>PMID: 26614412</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Acute Kidney Injury - epidemiology ; aortic stenosis ; Aortic Valve - diagnostic imaging ; Aortic Valve - physiopathology ; Aortic Valve - surgery ; Aortic Valve Stenosis - diagnosis ; Aortic Valve Stenosis - mortality ; Aortic Valve Stenosis - physiopathology ; Aortic Valve Stenosis - surgery ; Aortic Valve Stenosis - therapy ; Bioprosthesis ; Cardiac Catheterization - adverse effects ; Cardiac Catheterization - instrumentation ; Cardiac Catheterization - mortality ; Cardiothoracic Surgery ; Echocardiography, Doppler ; Heart Valve Prosthesis ; Heart Valve Prosthesis Implantation - adverse effects ; Heart Valve Prosthesis Implantation - instrumentation ; Heart Valve Prosthesis Implantation - mortality ; Humans ; Incidence ; Kaplan-Meier Estimate ; Postoperative Complications - diagnosis ; Postoperative Complications - epidemiology ; Postoperative Complications - mortality ; Proportional Hazards Models ; Prospective Studies ; Prosthesis Design ; prosthesis-patient mismatch ; Risk Assessment ; Risk Factors ; Severity of Illness Index ; Time Factors ; transcatheter aortic valve replacement ; Treatment Outcome ; United States - epidemiology ; Ventricular Function, Left ; Ventricular Remodeling</subject><ispartof>The Journal of thoracic and cardiovascular surgery, 2016-04, Vol.151 (4), p.1014-1023.e3</ispartof><rights>The American Association for Thoracic Surgery</rights><rights>2016 The American Association for Thoracic Surgery</rights><rights>Copyright © 2016 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c459t-c7fa03d60c796e473626ff16de414a534f70d493176385c511e20cc0e4fde2173</citedby><cites>FETCH-LOGICAL-c459t-c7fa03d60c796e473626ff16de414a534f70d493176385c511e20cc0e4fde2173</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0022522315021339$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26614412$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zorn, George L., MD</creatorcontrib><creatorcontrib>Little, Stephen H., MD</creatorcontrib><creatorcontrib>Tadros, Peter, MD</creatorcontrib><creatorcontrib>Deeb, G. Michael, MD</creatorcontrib><creatorcontrib>Gleason, Thomas G., MD</creatorcontrib><creatorcontrib>Heiser, John, MD</creatorcontrib><creatorcontrib>Kleiman, Neal S., MD</creatorcontrib><creatorcontrib>Oh, Jae K., MD</creatorcontrib><creatorcontrib>Popma, Jeffrey J., MD</creatorcontrib><creatorcontrib>Adams, David, MD</creatorcontrib><creatorcontrib>Huang, Jian, MD</creatorcontrib><creatorcontrib>Reardon, Michael J., MD</creatorcontrib><title>Prosthesis–patient mismatch in high-risk patients with severe aortic stenosis: A randomized trial of a self-expanding prosthesis</title><title>The Journal of thoracic and cardiovascular surgery</title><addtitle>J Thorac Cardiovasc Surg</addtitle><description>Abstract Objectives We compared the incidence of prosthesis–patient mismatch (PPM) between transcatheter aortic valve replacement (TAVR) using a self-expanding bioprosthesis and surgical aortic valve replacement (SAVR) in the CoreValve US High Risk Pivotal Trial. We sought to determine the influence of PPM on clinical outcomes. Methods Patients with severe aortic stenosis and at increased risk for surgery were randomized 1:1 to TAVR or SAVR. Postoperative PPM was defined by the effective orifice area index (EOAi) as severe PPM (EOAi ≤ 0.65 cm2 /m2 ) and no severe PPM (EOAi &gt; 0.65 cm2 /m2 ); clinical outcomes were analyzed in the TAVR arm (n = 389) and SAVR arm (n = 353). Left ventricular mass index and regression were analyzed at baseline and 1 year. Results The incidence of severe PPM in the SAVR group at 1 year was 25.7% versus 6.2% in the TAVR group ( P  &lt; .0001). Left ventricular mass index regression at 1 year was 6.8% for TAVR and 15.1% for SAVR in patients with severe PPM. At 1 year the rate of all-cause mortality and acute kidney injury were significantly greater in all patients (TAVR + SAVR) with severe PPM compared with no severe PPM (20.6% vs 12.0% [ P  = .0145] for death and 19.2% vs 8.5% [ P  = .0008] for acute kidney injury). Conclusions In patients with high surgical risk and severe aortic stenosis, severe PPM is more common in patients treated with SAVR than those treated with TAVR. Patients with severe PPM are a greater risk for death and acute kidney injury than patients without severe PPM.</description><subject>Acute Kidney Injury - epidemiology</subject><subject>aortic stenosis</subject><subject>Aortic Valve - diagnostic imaging</subject><subject>Aortic Valve - physiopathology</subject><subject>Aortic Valve - surgery</subject><subject>Aortic Valve Stenosis - diagnosis</subject><subject>Aortic Valve Stenosis - mortality</subject><subject>Aortic Valve Stenosis - physiopathology</subject><subject>Aortic Valve Stenosis - surgery</subject><subject>Aortic Valve Stenosis - therapy</subject><subject>Bioprosthesis</subject><subject>Cardiac Catheterization - adverse effects</subject><subject>Cardiac Catheterization - instrumentation</subject><subject>Cardiac Catheterization - mortality</subject><subject>Cardiothoracic Surgery</subject><subject>Echocardiography, Doppler</subject><subject>Heart Valve Prosthesis</subject><subject>Heart Valve Prosthesis Implantation - adverse effects</subject><subject>Heart Valve Prosthesis Implantation - instrumentation</subject><subject>Heart Valve Prosthesis Implantation - mortality</subject><subject>Humans</subject><subject>Incidence</subject><subject>Kaplan-Meier Estimate</subject><subject>Postoperative Complications - diagnosis</subject><subject>Postoperative Complications - epidemiology</subject><subject>Postoperative Complications - mortality</subject><subject>Proportional Hazards Models</subject><subject>Prospective Studies</subject><subject>Prosthesis Design</subject><subject>prosthesis-patient mismatch</subject><subject>Risk Assessment</subject><subject>Risk Factors</subject><subject>Severity of Illness Index</subject><subject>Time Factors</subject><subject>transcatheter aortic valve replacement</subject><subject>Treatment Outcome</subject><subject>United States - epidemiology</subject><subject>Ventricular Function, Left</subject><subject>Ventricular Remodeling</subject><issn>0022-5223</issn><issn>1097-685X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcuKFTEQhoMoznH0CQTJ0k0fU7lOCwrD4A0GFFRwF2K6ejo9fTkmOWccV-Ir-IY-iWnPcRZuXAWq_r_-1FeEPAS2Bgb6Sb_us9-lNWegSmXNDLtFVsBqU-kT9ek2WTHGeaU4F0fkXko9Y0UC9V1yxLUGKYGvyI93cU65wxTSr-8_Ny4HnDIdQxpd9h0NE-3CRVfFkC7poZvoVcgdTbjDiNTNMQdPU8ZpLkOe0lMa3dTMY_iGDc0xuIHOLXVFP7QVft2UZpgu6OYm9z6507oh4YPDe0w-vnzx4ex1df721Zuz0_PKS1XnypvWMdFo5k2tURqhuW5b0A1KkE4J2RrWyFqA0eJEeQWAnHnPULYNcjDimDzezy3RX7aYsi1rehwGN-G8TRaMUaAVk7xIxV7qyy9TxNZuYhhdvLbA7ALf9vYPfLvAX4qFbHE9OgRsP4_Y3Hj-0i6CZ3sBljV3AaNNvhD12ISIPttmDv8JeP6P3w9hCt4Nl3iNqZ-3cSoELdjELbPvl_sv5wfFOAhRi99kZa6w</recordid><startdate>20160401</startdate><enddate>20160401</enddate><creator>Zorn, George L., MD</creator><creator>Little, Stephen H., MD</creator><creator>Tadros, Peter, MD</creator><creator>Deeb, G. Michael, MD</creator><creator>Gleason, Thomas G., MD</creator><creator>Heiser, John, MD</creator><creator>Kleiman, Neal S., MD</creator><creator>Oh, Jae K., MD</creator><creator>Popma, Jeffrey J., MD</creator><creator>Adams, David, MD</creator><creator>Huang, Jian, MD</creator><creator>Reardon, Michael J., MD</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20160401</creationdate><title>Prosthesis–patient mismatch in high-risk patients with severe aortic stenosis: A randomized trial of a self-expanding prosthesis</title><author>Zorn, George L., MD ; Little, Stephen H., MD ; Tadros, Peter, MD ; Deeb, G. Michael, MD ; Gleason, Thomas G., MD ; Heiser, John, MD ; Kleiman, Neal S., MD ; Oh, Jae K., MD ; Popma, Jeffrey J., MD ; Adams, David, MD ; Huang, Jian, MD ; Reardon, Michael J., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c459t-c7fa03d60c796e473626ff16de414a534f70d493176385c511e20cc0e4fde2173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Acute Kidney Injury - epidemiology</topic><topic>aortic stenosis</topic><topic>Aortic Valve - diagnostic imaging</topic><topic>Aortic Valve - physiopathology</topic><topic>Aortic Valve - surgery</topic><topic>Aortic Valve Stenosis - diagnosis</topic><topic>Aortic Valve Stenosis - mortality</topic><topic>Aortic Valve Stenosis - physiopathology</topic><topic>Aortic Valve Stenosis - surgery</topic><topic>Aortic Valve Stenosis - therapy</topic><topic>Bioprosthesis</topic><topic>Cardiac Catheterization - adverse effects</topic><topic>Cardiac Catheterization - instrumentation</topic><topic>Cardiac Catheterization - mortality</topic><topic>Cardiothoracic Surgery</topic><topic>Echocardiography, Doppler</topic><topic>Heart Valve Prosthesis</topic><topic>Heart Valve Prosthesis Implantation - adverse effects</topic><topic>Heart Valve Prosthesis Implantation - instrumentation</topic><topic>Heart Valve Prosthesis Implantation - mortality</topic><topic>Humans</topic><topic>Incidence</topic><topic>Kaplan-Meier Estimate</topic><topic>Postoperative Complications - diagnosis</topic><topic>Postoperative Complications - epidemiology</topic><topic>Postoperative Complications - mortality</topic><topic>Proportional Hazards Models</topic><topic>Prospective Studies</topic><topic>Prosthesis Design</topic><topic>prosthesis-patient mismatch</topic><topic>Risk Assessment</topic><topic>Risk Factors</topic><topic>Severity of Illness Index</topic><topic>Time Factors</topic><topic>transcatheter aortic valve replacement</topic><topic>Treatment Outcome</topic><topic>United States - epidemiology</topic><topic>Ventricular Function, Left</topic><topic>Ventricular Remodeling</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zorn, George L., MD</creatorcontrib><creatorcontrib>Little, Stephen H., MD</creatorcontrib><creatorcontrib>Tadros, Peter, MD</creatorcontrib><creatorcontrib>Deeb, G. Michael, MD</creatorcontrib><creatorcontrib>Gleason, Thomas G., MD</creatorcontrib><creatorcontrib>Heiser, John, MD</creatorcontrib><creatorcontrib>Kleiman, Neal S., MD</creatorcontrib><creatorcontrib>Oh, Jae K., MD</creatorcontrib><creatorcontrib>Popma, Jeffrey J., MD</creatorcontrib><creatorcontrib>Adams, David, MD</creatorcontrib><creatorcontrib>Huang, Jian, MD</creatorcontrib><creatorcontrib>Reardon, Michael J., MD</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of thoracic and cardiovascular surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zorn, George L., MD</au><au>Little, Stephen H., MD</au><au>Tadros, Peter, MD</au><au>Deeb, G. Michael, MD</au><au>Gleason, Thomas G., MD</au><au>Heiser, John, MD</au><au>Kleiman, Neal S., MD</au><au>Oh, Jae K., MD</au><au>Popma, Jeffrey J., MD</au><au>Adams, David, MD</au><au>Huang, Jian, MD</au><au>Reardon, Michael J., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prosthesis–patient mismatch in high-risk patients with severe aortic stenosis: A randomized trial of a self-expanding prosthesis</atitle><jtitle>The Journal of thoracic and cardiovascular surgery</jtitle><addtitle>J Thorac Cardiovasc Surg</addtitle><date>2016-04-01</date><risdate>2016</risdate><volume>151</volume><issue>4</issue><spage>1014</spage><epage>1023.e3</epage><pages>1014-1023.e3</pages><issn>0022-5223</issn><eissn>1097-685X</eissn><abstract>Abstract Objectives We compared the incidence of prosthesis–patient mismatch (PPM) between transcatheter aortic valve replacement (TAVR) using a self-expanding bioprosthesis and surgical aortic valve replacement (SAVR) in the CoreValve US High Risk Pivotal Trial. We sought to determine the influence of PPM on clinical outcomes. Methods Patients with severe aortic stenosis and at increased risk for surgery were randomized 1:1 to TAVR or SAVR. Postoperative PPM was defined by the effective orifice area index (EOAi) as severe PPM (EOAi ≤ 0.65 cm2 /m2 ) and no severe PPM (EOAi &gt; 0.65 cm2 /m2 ); clinical outcomes were analyzed in the TAVR arm (n = 389) and SAVR arm (n = 353). Left ventricular mass index and regression were analyzed at baseline and 1 year. Results The incidence of severe PPM in the SAVR group at 1 year was 25.7% versus 6.2% in the TAVR group ( P  &lt; .0001). Left ventricular mass index regression at 1 year was 6.8% for TAVR and 15.1% for SAVR in patients with severe PPM. At 1 year the rate of all-cause mortality and acute kidney injury were significantly greater in all patients (TAVR + SAVR) with severe PPM compared with no severe PPM (20.6% vs 12.0% [ P  = .0145] for death and 19.2% vs 8.5% [ P  = .0008] for acute kidney injury). Conclusions In patients with high surgical risk and severe aortic stenosis, severe PPM is more common in patients treated with SAVR than those treated with TAVR. Patients with severe PPM are a greater risk for death and acute kidney injury than patients without severe PPM.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26614412</pmid><doi>10.1016/j.jtcvs.2015.10.070</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-5223
ispartof The Journal of thoracic and cardiovascular surgery, 2016-04, Vol.151 (4), p.1014-1023.e3
issn 0022-5223
1097-685X
language eng
recordid cdi_proquest_miscellaneous_1775165042
source MEDLINE; Elsevier ScienceDirect Journals; EZB-FREE-00999 freely available EZB journals
subjects Acute Kidney Injury - epidemiology
aortic stenosis
Aortic Valve - diagnostic imaging
Aortic Valve - physiopathology
Aortic Valve - surgery
Aortic Valve Stenosis - diagnosis
Aortic Valve Stenosis - mortality
Aortic Valve Stenosis - physiopathology
Aortic Valve Stenosis - surgery
Aortic Valve Stenosis - therapy
Bioprosthesis
Cardiac Catheterization - adverse effects
Cardiac Catheterization - instrumentation
Cardiac Catheterization - mortality
Cardiothoracic Surgery
Echocardiography, Doppler
Heart Valve Prosthesis
Heart Valve Prosthesis Implantation - adverse effects
Heart Valve Prosthesis Implantation - instrumentation
Heart Valve Prosthesis Implantation - mortality
Humans
Incidence
Kaplan-Meier Estimate
Postoperative Complications - diagnosis
Postoperative Complications - epidemiology
Postoperative Complications - mortality
Proportional Hazards Models
Prospective Studies
Prosthesis Design
prosthesis-patient mismatch
Risk Assessment
Risk Factors
Severity of Illness Index
Time Factors
transcatheter aortic valve replacement
Treatment Outcome
United States - epidemiology
Ventricular Function, Left
Ventricular Remodeling
title Prosthesis–patient mismatch in high-risk patients with severe aortic stenosis: A randomized trial of a self-expanding prosthesis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T15%3A59%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prosthesis%E2%80%93patient%20mismatch%20in%20high-risk%20patients%20with%20severe%20aortic%20stenosis:%20A%20randomized%20trial%20of%20a%20self-expanding%20prosthesis&rft.jtitle=The%20Journal%20of%20thoracic%20and%20cardiovascular%20surgery&rft.au=Zorn,%20George%20L.,%20MD&rft.date=2016-04-01&rft.volume=151&rft.issue=4&rft.spage=1014&rft.epage=1023.e3&rft.pages=1014-1023.e3&rft.issn=0022-5223&rft.eissn=1097-685X&rft_id=info:doi/10.1016/j.jtcvs.2015.10.070&rft_dat=%3Cproquest_cross%3E1775165042%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1775165042&rft_id=info:pmid/26614412&rft_els_id=S0022522315021339&rfr_iscdi=true